Emocha Health is a Baltimore, Maryland-based digital health company that offers Digital Medication Adherence Programs enabling patients to take every dose via video technology and scalable human engagement. It partners with health plans, health systems, employers and health departments across the U.S. to improve adherence for patients with diabetes, asthma, tuberculosis and other chronic and infectious diseases. The company operates a remote clinical team of nurses and pharmacists that engages patients at scale. Emocha raised $6.2M in a Series A to expand strategic integrations and grow its remote clinical team. The funding is intended to help respond to demand from health plans and transplant centers across the United States. Sebastian Seiguer is CEO. emocha Mobile Health builds a mobile video technology platform used to support medication adherence for tuberculosis and other conditions. The platform is currently in use at sites in California and Puerto Rico and a Maryland phase showed 94% patient adherence and average public-health savings of $1,391 per patient. Researchers from Johns Hopkins School of Medicine will use a $1M NIH Small Business Innovation Research grant to evaluate the platform at those sites and at a third site in Minnesota where it is not yet in use; the study will run two years. The grant will also fund pilots in Guam and New Jersey. emocha is beginning a second phase of research, funded by a separate federal grant, to evaluate use of the platform for buprenorphine treatment for opioid addiction at the University of Washington and Boston Medical Center. The company has about 12 employees and is recruiting for roles in design and development. emocha Mobile Health is a Baltimore, MD-based medication adherence platform provider that uses video-based technology. The company closed a $1M seed funding round from a group of investors. It will use the funds to expand sales efforts and tailor the technology for opioid use disorder treatment. Led by CEO Sebastian Seiguer, emocha provides a video-based adherence platform powered by healthcare providers. The company works with payers, providers, and health departments to reduce costs and support patients with conditions such as tuberculosis, hepatitis C, and opioid addiction.

Total raised

$8M

Funding rounds

3

Latest round

Series A

Latest activity

May 2021